Assist. Prof. Dr. Leila Abbasi | Causes and Symptoms of Infectious Diseases | Best Researcher Award

Published on by Infectious

Assist. Prof. Dr. Leila Abbasi | Causes and Symptoms of Infectious Diseases | Best Researcher Award

Assisstant Professor | Shiraz University of Medical Sciences | Iran

Dr. Leila Abbasi is an Assistant Professor of Physiotherapy at Shiraz University of Medical Sciences, renowned for her expertise in neurological and musculoskeletal rehabilitation. She earned her Bachelor’s, Master’s, and PhD degrees in Physiotherapy, consistently ranking first throughout her academic career and being recognized as a member of the National Elite Foundation. Her professional journey spans academic teaching, clinical practice, and research leadership, including her role as founder and technical manager of Mehravar Physiotherapy Clinic and faculty member at the Shiraz Rehabilitation Faculty. Dr. Abbasi’s research focuses on exercise therapy, biomechanics, neurorehabilitation, and clinical interventions for conditions such as cerebral palsy, stroke, and musculoskeletal disorders. She has authored numerous peer-reviewed articles in leading journals indexed in Scopus and PubMed and co-authored a book on Clinical Analysis of Gait. A distinguished educator, she has organized and instructed many national and international workshops and conferences on advanced physiotherapy methods. Her academic excellence is reflected in multiple top-rank awards, research grants, and recognitions for innovation in rehabilitation sciences. She is an active member of scientific committees and editorial boards and continues to contribute to the development of rehabilitation education and clinical protocols, making her a notable leader and innovator in physiotherapy research and practice. Her scholarly impact is demonstrated by 398 citations, an h-index of 10, and an i10-index of 10, and 243 citations, an h-index of 8, and an i10-index of 8.

Profiles : Google Scholar

Featured Publications

Leila Abbasi*, Long-term effects of COVID-19 on cardiopulmonary health, muscle strength, and quality of life: A comparative study. Respir. Med., 2025, 247, 108302.

Leila Abbasi*, The effect of rotator cuff trigger points dry needling on the stability and function of the upper limb in people with shoulder pain: A randomized clinical trial. J. Hand Ther., 2025.

Leila Abbasi*, The effect of combined dry needling and stretching exercises on pain and function in patients with patellofemoral pain: A randomized clinical trial. J. Bodyw. Mov. Ther., 2025.

Leila Abbasi*, Investigating the effects of adding kinesio taping to diaphragm strengthening exercises on pain, function, and balance in women athletes with chronic non-specific low back pain. J. Rehabil. Sci. Res., 2025.

Assist. Prof. Dr. Teshome Gemechu | Infectious Diseases | Best Researcher Award

Published on by Infectious

Assist. Prof. Dr. Teshome Gemechu | Infectious Diseases | Best Researcher Award

Instructor and Researcher | Madda Walabu University | Ethiopia

Dr. Teshome Gemechu Chawicha is an Assistant Professor at Madda Walabu University, Ethiopia, specializing in Animal and Range Sciences with a strong research background in climate-smart agriculture and livestock production management. He earned his Ph.D. in Climate Smart Agriculture and Biodiversity Management from Haramaya University, where he focused on livestock production and management, complemented by an MSc in Dairy Science and a BSc in Animal and Range Science. His international academic exposure includes an International Diploma in Animal Feed from PTC+ Barneveld, Netherlands, and professional certifications in Artificial Intelligence Fundamentals, Data Analysis, and Fisheries Governance for Food Security. Dr. Teshome has held multiple academic and research leadership roles, including Department Head of Animal Science and researcher with global organizations such as GIZ, CIP, and Save the Children, contributing to climate change adaptation, livestock productivity, and sustainable rangeland management projects. His research encompasses dairy science, biodiversity conservation, animal health, and climate resilience, with numerous peer-reviewed publications in leading journals such as Food Chemistry Advances and African Journal of Agricultural Research. He has also served as a reviewer and internal evaluator for postgraduate curricula, reflecting his academic rigor and institutional leadership. A recipient of the World Bank–sponsored Ph.D. fellowship and Dutch Ministry of Foreign Affairs scholarship, Dr. Teshome is recognized for his contributions to livestock development, climate-smart innovations, and community-centered agricultural projects, making him a distinguished candidate for academic and research excellence awards. His scholarly record includes 5 citations, 3 published documents, and an h-index of 1.

Profiles : Scopus 

Featured Publications

Teshome Gemechu Chawicha*, Honeybee pests, predators and diseases in the selected districts of Bench-Maji and Sheka zones, Southwest Ethiopia. African Journal of Agricultural Research (AJAR), 2024, 20(5), 402–410.

Teshome Gemechu Chawicha, Rangeland biodiversity: status, challenges and opportunities review. Journal of Rangeland Science (JRS), 2023, 13(3), 132326.

Teshome Gemechu Chawicha, An overview of how heat stress impacts dairy cattle fertility. Multidisciplinary Reviews, 2022, 5(3), e2022014.

Teshome Gemechu Chawicha, Antimicrobial susceptibility of major bacterial pathogens isolated from bovine mastitis in Bench Maji zone, Southwest Ethiopia. Multidisciplinary Science Journal, 2021, 3, e20210010.

Ms. Sankwetea Prudent Mokgokong | Veterinary microbiology | Best Researcher Award

Published on by Infectious

Ms. Sankwetea Prudent Mokgokong | Veterinary microbiology | Best Researcher Award

Lecturer | North-West University | South Africa

Ms. Sankwetea Prudent Mokgokong is an accomplished academic specializing in Veterinary Microbiology, demonstrating exceptional expertise in genomics, metagenomics, and molecular biology. Her educational foundation in microbiology and chemistry, complemented by advanced research in Veterinary Microbiology, has empowered her to contribute significantly to microbial diversity and genetic studies across various biological systems. Throughout her professional career at institutions such as the North-West University and the South African National Biodiversity Institute, she has actively engaged in teaching, molecular biology research, and next-generation sequencing management—key pillars in Veterinary Microbiology research. Her scholarly pursuits emphasize Veterinary Microbiology applications in animal health, population genetics, and disease monitoring, showcasing her skill in analyzing microbial communities and genomic variations relevant to animal systems. She has authored multiple publications addressing antimicrobial resistance, genomic diversity, and microbial ecology—all rooted in Veterinary Microbiology principles. Recognized for her dedication and contributions, she has received academic honors and led bioinformatics training programs, strengthening capacity building in Veterinary Microbiology research. Her technical skills span bioinformatics, genome assembly, SNP analysis, microbial phylogenetics, and high-performance computing—all central to Veterinary Microbiology innovation. Ms. Mokgokong’s work reflects an unrelenting commitment to advancing Veterinary Microbiology, bridging molecular science, bioinformatics, and animal health. Her achievements in Veterinary Microbiology demonstrate her leadership in genomic data interpretation, laboratory management, and research mentorship. With an enduring passion for Veterinary Microbiology, she continues to influence conservation genetics, microbial ecology, and forensic microbiology through her analytical precision and scientific vision, positioning her as an emerging leader in Veterinary Microbiology excellence across academic and applied biosciences.

Profiles: Google Scholar | ORCID

Featured Publications

1. Mwale, M., Dalton, D. L., Jansen, R., De Bruyn, M., Pietersen, D., Mokgokong, P. S., … (2017). Forensic application of DNA barcoding for identification of illegally traded African pangolin scales. Genome, 60(3), 272–284.

2. Loots, A. K., Mokgokong, P. S., Mitchell, E., Venter, E. H., Kotze, A., & Dalton, D. L. (2018). Phylogenetic analysis of canine distemper virus in South African wildlife. PLoS One, 13(7), e0199993.

3. Ramatla, T., Mokgokong, P., Lekota, K., & Thekisoe, O. (2024). Antimicrobial resistance profiles of Pseudomonas aeruginosa, Escherichia coli and Klebsiella pneumoniae strains isolated from broiler chickens. Food Microbiology, 120, 104476.

4. Ramatla, T., Tutubala, M., Motlhaping, T., de Wet, L., Mokgokong, P., … (2024). Molecular detection of Shiga toxin and extended-spectrum beta-lactamase (ESBL)-producing Escherichia coli isolates from sheep and goats. Molecular Biology Reports, 51(1), 57.

5. Ramatla, T., Khasapane, N. G., Mlangeni, L. N., Mokgokong, P., Ramaili, T., … (2024). Detection of Salmonella pathogenicity islands and antimicrobial-resistant genes in Salmonella enterica serovars Enteritidis and Typhimurium isolated from … Antibiotics, 13(5), 458.

Dr. Elham Kazemirad | Treatment for Infectious Diseases | Excellence in Research

Published on by Infectious

Dr. Elham Kazemirad | Treatment for Infectious Diseases | Excellence in Research

Associate Professor at Tehran University of Medical Sciences, Iran

Dr. Elham Kazemirad is a renowned Associate Professor at the Department of Medical Parasitology and Mycology, Tehran University of Medical Sciences. Her research bridges clinical and molecular diagnostics, with a central focus on Treatment for Infectious Diseases. Over the years, her contributions have emphasized Treatment for Infectious Diseases across leishmaniasis, Acanthamoeba keratitis, and protozoan infections. Her work consistently explores innovative diagnostic and therapeutic strategies, reinforcing global capabilities in Treatment for Infectious Diseases. With a dynamic presence in academia, she has dedicated her career to advancing Treatment for Infectious Diseases through cutting-edge molecular biology, gene expression studies, and nanoparticle drug delivery. Dr. Kazemirad’s leadership and research continue shaping new pathways for Treatment for Infectious Diseases in both clinical and research settings.

Professional Profile 

ORCID | Google Scholar

Education

Dr. Kazemirad holds a Ph.D., M.Sc., B.Sc., and Associate Degree in Medical Parasitology and Laboratory Sciences, all from top Iranian medical universities. Her Ph.D. thesis pioneered gene profiling in Leishmania tropica and explored mechanisms of drug resistance, directly contributing to Treatment for Infectious Diseases. Throughout her academic path, Treatment for Infectious Diseases remained a core theme, evident in her early thesis on PCR diagnostics and parasite detection. Her educational foundation was rigorously rooted in scientific innovation and clinical relevance, always aimed at improving Treatment for Infectious Diseases. This background has propelled her to become a thought leader whose educational milestones support groundbreaking discoveries in the Treatment for Infectious Diseases field.

Experience

Dr. Kazemirad has served as an Assistant and Associate Professor, and lab supervisor, contributing significantly to Treatment for Infectious Diseases . Her clinical laboratory leadership includes molecular diagnosis of parasitic diseases, microbial keratitis, and more, always reinforcing effective Treatment for Infectious Diseases. She combines teaching, clinical, and administrative roles to shape future parasitologists and advance diagnostics. At both Tehran University of Medical Sciences and Pasteur Institute of Iran, her dedication has been a cornerstone in Treatment for Infectious Diseases. She mentors students and leads research initiatives that redefine how Treatment for Infectious Diseases is applied and understood across academic, diagnostic, and healthcare platforms.

Research Interest

Dr. Kazemirad’s primary research interests center on drug resistance mechanisms, molecular diagnostics, and nanomedicine all critical for effective Treatment for Infectious Diseases. Her passion for Treatment for Infectious Diseases drives projects involving gene expression in pathogens and the development of novel therapeutics. With expertise in biotechnology, immunology, and phylogenetics, she investigates the molecular basis of resistance and innovative drug delivery systems. Treatment for Infectious Diseases is not only her research focus but her mission. By integrating bioinformatics, molecular assays, and nanoparticle therapeutics, her research contributes vital knowledge and practical tools to improve Treatment for Infectious Diseases, especially among vulnerable and immunocompromised populations.

Awards and Honors

Dr. Kazemirad has been consistently recognized for her academic excellence and innovation in Treatment for Infectious Diseases. She was ranked first in multiple academic programs and received distinctions for her graduate work in drug-resistant Leishmania. Her work in Treatment for Infectious Diseases has been honored through leadership roles in scientific congresses and editorial positions in top journals. These honors reflect her relentless commitment to advancing Treatment for Infectious Diseases through translational research and public health applications. The prestigious recognition from both Iranian and international institutions underscores her profound impact on Treatment for Infectious Diseases and her standing as a key contributor in parasitological and biomedical sciences.

Research Skills

Dr. Kazemirad is proficient in molecular diagnostics, gene expression analysis, animal modeling, and nanoparticle-based therapeutics, all pivotal for enhancing Treatment for Infectious Diseases. Her skill set includes advanced techniques such as RT-PCR, Western blotting, cloning, proteomics, ELISA, gene silencing, and next-generation sequencing. Each technique is applied to understand, monitor, and improve Treatment for Infectious Diseases. Her expertise extends to developing diagnostic platforms for Acanthamoeba and Leishmania, along with testing novel compounds and nanoparticles. Treatment for Infectious Diseases is the core of her methodological approach, combining lab innovation with clinical relevance to transform how these diseases are managed and treated across diverse populations.

Publications

Title: Contribution of epidermal growth factor (EGF) in the treatment of cutaneous leishmaniasis caused by Leishmania major in BALB/c mice
Authors: Saberi, M.; Latifi, A.; Golkar, M.; Fard-Esfahani, P.; Mohtasebi, S.; Teimouri, A.; Afshar, M.J.A.; Kazemirad, E.; Mohebali, M.
Journal: PLoS Neglected Tropical Diseases

Title: High Prevalence of Enterocytozoon bieneusi Genotype BEB6 in Wild Boars in Lorestan Province, Iran: Potential Source of Zoonotic Transmission
Authors: Javanmard, E.; Mohammad Rahimi, H.; Taghipour, A.; Nemati, S.; Mohebali, M.; Rezaeian, M.; Badrifar, A.; Kazemirad, E.; Mirjalali, H.
Journal: Iranian Journal of Parasitology

Title: Molecular Identification of Nematodes (Superfamily: Strongylida) Traced in Herbivores Excrement in the Wildlife from Western Iran
Authors: Vafaei, M.R.; Safaie, M.; Kazemirad, E.; Mirjalali, H.; Askari, Z.; Mohebali, M.; Mowlavi, G.
Journal: SSRN

Title: Prevalence of free-living amoebae in five rivers associated with high human activity in Tehran province, Iran
Authors: Javanmard, E.; Kazemirad, E.; Rahimi, H.M.; Mohebali, M.; Rezaeian, M.; Alimohammadi, M.; Mirjalali, H.
Journal: Journal of Water and Health

Title: Transcriptional alterations of virulence factors in Leishmania major clinical isolates harboring Leishmania RNA virus 2 (LRV2)
Authors: Sabeti, S.; Koosha, M.; Kazemirad, E.; Mirabedini, Z.; Mohebali, M.; Saberi, R.; Fakhar, M.; Hajjaran, H.
Journal: BMC Infectious Diseases

CONCLUSION

Dr. Elham Kazemirad’s career epitomizes dedication to the Treatment for Infectious Diseases. Through her education, research, and professional engagements, she has elevated global understanding of parasitic diseases and their therapies. Her work integrates basic science and clinical innovation to offer novel solutions for Treatment for Infectious Diseases. From academic contributions to pioneering diagnostics and therapies, her impact is profound and ongoing. She remains a key influencer in shaping policies, mentoring future scientists, and leading research that targets resistant pathogens. As Treatment for Infectious Diseases continues to challenge global health, her expertise remains vital in guiding next-generation therapeutic advancements and public health solutions.

Ikram Omar Osman – Virology – Best Researcher Award

Published on by Infectious

Ikram Omar Osman - Virology - Best Researcher Award

Caisse Nationale de Sécurité Sociale - Djibouti

AUTHOR PROFILE 

GOOGLE SCHOLAR

EARLY ACADEMIC FOUNDATIONS 🎓

Dr. Ikram Omar Osman’s academic journey began with a strong passion for medical science, leading him to earn his MBBS from the University of Khartoum in Sudan in 2002. His commitment to nephrology developed during his early clinical years, which sparked further postgraduate training. He later earned an MD in Internal Medicine, followed by a Fellowship in Nephrology, laying a comprehensive academic and clinical foundation. His pursuit of excellence led him to Malaysia, where he completed advanced nephrology training and gained regional and international exposure. These formative academic experiences, coupled with exposure to diverse healthcare systems, not only honed his clinical insight but also nurtured a multidisciplinary approach to kidney care. Throughout his education, he remained deeply committed to evidence-based medicine and clinical research, which shaped his subsequent professional focus. His early academic years clearly set the stage for his emerging influence in the field of nephrology and healthcare development in resource-limited settings.

PROFESSIONAL ENDEAVORS IN NEPHROLOGY 🏥

Dr. Osman’s professional journey has been marked by a series of pivotal roles in both clinical and academic nephrology. As a Consultant Nephrologist at the Ministry of Health in Sudan and a key faculty member at the University of Medical Sciences and Technology (UMST), he has merged clinical practice with academic mentorship. He has significantly contributed to the establishment and development of dialysis and transplant programs across Sudan, often working in resource-constrained environments. His efforts in optimizing nephrology services reflect his dedication to patient-centered care and sustainable health solutions. Additionally, his involvement in clinical teaching at UMST has allowed him to mentor a new generation of nephrologists. His leadership in national nephrology initiatives, including his role in the Sudanese Nephrology Society, underlines his vision for expanding kidney care accessibility and quality. Dr. Osman’s multifaceted professional activities exemplify his deep-rooted commitment to advancing nephrology in developing countries.

RESEARCH FOCUS AND SCIENTIFIC CONTRIBUTIONS 🔬

Dr. Osman’s research is driven by real-world challenges in nephrology, especially those prevalent in low- and middle-income countries. His work focuses on renal replacement therapies, transplantation, and chronic kidney disease (CKD) management within limited-resource settings. He has published extensively on epidemiology, dialysis outcomes, and healthcare delivery, contributing valuable data that guide national and regional nephrology policies. His participation in international research collaborations has expanded the reach of Sudanese nephrology into the global scientific arena. Notably, his research addresses local disease patterns, cultural influences on treatment adherence, and innovative low-cost interventions to enhance kidney care. As an advocate for research translation, Dr. Osman integrates findings directly into clinical practice and national policy discussions. His scholarly activities reflect a blend of scientific rigor and humanitarian concern, highlighting his role not just as a researcher but as a problem-solver for the underserved kidney patient population in Africa.

REGIONAL AND GLOBAL ENGAGEMENT 🌍

Dr. Osman has played a prominent role in both regional and international nephrology communities. He has actively collaborated with organizations such as the International Society of Nephrology (ISN), where he contributes to global kidney health initiatives, especially those targeting resource-poor areas. His participation in ISN's Sister Renal Centers Program and involvement in capacity-building projects have directly impacted the development of nephrology infrastructure in Sudan and neighboring countries. He has represented Sudan in multiple international forums and conferences, bringing forward the challenges and successes of nephrology in Africa. His ability to bridge local healthcare realities with global nephrology standards has earned him recognition as a key regional leader. Dr. Osman’s global engagements serve not only to elevate Sudanese nephrology on the world stage but also to advocate for equity and innovation in kidney healthcare delivery across underrepresented populations.

TEACHING, MENTORSHIP, AND ACADEMIC SERVICE 👨‍🏫

A passionate educator, Dr. Osman is deeply involved in training the next generation of physicians and nephrologists. As a faculty member at UMST and through his involvement with postgraduate nephrology training programs, he has mentored countless students and junior doctors. His teaching philosophy integrates evidence-based medicine with local healthcare relevance, fostering critical thinking and practical skills among his trainees. Beyond classroom teaching, he has supervised research projects and guided young researchers in clinical studies, reinforcing his dedication to academic excellence. Dr. Osman also contributes to curriculum development and has helped structure standardized nephrology training across Sudan. His mentorship extends to international exchange programs, where he prepares students for global nephrology fellowships and training. Through his commitment to education, Dr. Osman not only disseminates knowledge but also shapes the ethical and professional standards of future healthcare providers in the region.

RECOGNITION AND HONORS 🏅

Throughout his career, Dr. Osman has received widespread recognition for his contributions to medicine and nephrology. His efforts in advancing kidney care have earned him national awards and commendations, highlighting his impact on Sudan’s healthcare landscape. His leadership in nephrology education and service development has been acknowledged by peers and academic institutions alike. Additionally, his inclusion in collaborative networks such as the ISN and invitations to speak at high-level conferences reflect the global respect he commands in the field. These honors are not merely ceremonial—they represent the tangible results of years of dedication to nephrology in settings with limited resources. His recognitions underscore a career built on integrity, resilience, and a drive to improve outcomes for patients with kidney disease, especially those in underserved regions. Dr. Osman’s accolades mirror his lifelong commitment to service, scholarship, and leadership in healthcare.

LEGACY AND FUTURE VISION FOR AFRICAN NEPHROLOGY 🔮

Dr. Ikram Omar Osman’s legacy lies in his enduring efforts to transform nephrology care in Sudan and across Africa. His pioneering work in dialysis access, transplant services, and nephrology education has created sustainable models of care that continue to benefit thousands. As he looks toward the future, Dr. Osman remains focused on strengthening healthcare systems, expanding training programs, and fostering South-South collaborations in nephrology. He envisions a future where equitable kidney care is a reality for all, regardless of geographic or economic barriers. His plans include deepening research into genetic and environmental factors of kidney disease in African populations and increasing local production of dialysis materials to reduce dependence on imports. His legacy is not only defined by what he has achieved, but by the inspiration he offers to future nephrologists. Through vision, action, and mentorship, Dr. Osman continues to shape the future of kidney health in Africa.

NOTABLE PUBLICATION

Title: Expression of ACE2, soluble ACE2, angiotensin I, angiotensin II and angiotensin-(1-7) is modulated in COVID-19 patients
Authors: IO Osman, C Melenotte, P Brouqui, M Million, JC Lagier, P Parola, A Stein, ...
Journal: Frontiers in Immunology

Title: Can ACE2 receptor polymorphism predict species susceptibility to SARS-CoV-2?
Authors: CA Devaux, L Pinault, IO Osman, D Raoult
Journal: Frontiers in Public Health

Title: Coxiella burnetii in Dromedary Camels (Camelus dromedarius): A Possible Threat for Humans and Livestock in North Africa and the Near and Middle East?
Authors: CA Devaux, IO Osman, M Million, D Raoult
Journal: Frontiers in Veterinary Science

Title: Control of CDH1/E-Cadherin Gene Expression and Release of a Soluble Form of E-Cadherin in SARS-CoV-2 Infected Caco-2 Intestinal Cells: Physiopathological Implications
Authors: IO Osman, C Garrec, GAP de Souza, A Zarubica, DB Belhaouari, ...
Journal: Frontiers in Cellular and Infection Microbiology

Title: High concentrations of serum soluble E-cadherin in patients with Q fever
Authors: S Mezouar, I Omar Osman, C Melenotte, C Slimani, C Chartier, D Raoult, ...
Journal: Frontiers in Cellular and Infection Microbiology